21 |
GENES AND PROCESSES FOR THE PRODUCTION OF CLAVINE-TYPE ALKALOIDS |
US14421872 |
2013-08-13 |
US20150211036A1 |
2015-07-30 |
Michael Naesby; Christophe Folly; Curt Aimé Friis Nielsen; Anaelle Hatsch; Markus Schwab; Oskar Zelder; Stefan Haefner; Hartwig Schroeder; Birgit Hoff; Andrea Molt; Klaus Ditrich; Michael Breuer; Holger Hartmann; Karsten Koerber |
Microorganisms and processes for the recombinant manufacture of clavine-type alkaloids such as cycloclavine, festuclavine, agroclavine, chanoclavine and chanoclavine aldehyde, as well as polypeptides, polynucleotides and vectors comprising such polynucleotides which can be applied in a method for the manufacture of clavine-type alkaloids are provided. |
22 |
Aromatic prenyltransferase from Cannabis |
US13389815 |
2010-08-04 |
US08884100B2 |
2014-11-11 |
Jonathan E. Page; Zakia Boubakir |
Nucleic acid molecules from Cannabis sativa (cannabis, hemp, marijuana) have been isolated and characterized, and encode polypeptides having aromatic prenyltransferase activity. Specifically, the enzyme, CsPT1, is a geranylpyrophosphate olivetolate geranyltransferase, active in the cannabinoid biosynthesis step of prenylation of olivetolic acid to form cannabigerolic acid (CBGA). Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds. |
23 |
METHOD FOR PRODUCING PYRIPYROPENE |
US13575159 |
2011-01-19 |
US20130023017A1 |
2013-01-24 |
Hiroyuki Anzai; Kentaro Yamamoto; Kazuhiko Oyama; Mariko Tsuchida; Kimihiko Goto; Masaaki Mitomi |
There is provided a method for culturing a microorganism in which a particular polynucleotide or a recombinant vector comprising it/them is introduced with an intermediate compound necessary for biosynthesis of pyripyropene. A. The method of the present invention allows for the production of pyripyropene. |
24 |
メバロン酸、イソプレノイド前駆体、及びイソプレンの産生におけるホスホケトラーゼの使用 |
JP2014534810 |
2012-10-05 |
JP6420147B2 |
2018-11-07 |
ベック、ザッカリー・キュー; エリオット、アンドリュー・シー; ペレス、キャロライン・エム; ヴァヴィライン、ドミートリ・ヴィ |
|
25 |
サイトカイニンシンターゼ酵素、構築物、および関連する方法 |
JP2016567970 |
2015-05-21 |
JP2017522001A |
2017-08-10 |
ティー. ビーソン,アイヴィ,ウィリアム; ジョン ウェストフォール,パトリック |
本開示は、2つのドメイン:イソペンテニル転移(IPT)様ドメイン、およびサイトカイニンヌクレオチドホスホリボヒドロラーゼ(PRH)様ドメインを有する新たなクラスのサイトカイニン生合成酵素であるサイトカイニンシンターゼに関する。本発明は、サイトカイニンシンターゼの組換え産生のための組成物および方法、サイトカイニンシンターゼを含む宿主細胞および形質転換体、ならびに開示されるサイトカイニンシンターゼを含む組成物および製剤を提供する。 |
26 |
ピリピロペンの製造法 |
JP2011551815 |
2011-01-19 |
JP5898960B2 |
2016-04-06 |
安西 弘行; 山本 憲太朗; 尾山 和彦; 土田 麻里子; 後藤 公彦; 三冨 正明 |
|
27 |
ピリピロペン生合成遺伝子群およびマーカー遺伝子を含む核酸構築物 |
JP2011551816 |
2011-01-19 |
JP5864267B2 |
2016-02-17 |
相原 智; 隅田 奈緒美; 村島 弘一郎; 矢内 耕二; 安西 弘行; 山本 憲太朗 |
|
28 |
クラビン類アルカロイドを製造するための遺伝子およびプロセス |
JP2015527987 |
2013-08-13 |
JP2015530879A |
2015-10-29 |
ゼルダー,オスカー; ヘフナー,シュテファン; シュレーダー,ハルトヴィッヒ; ホフ,ビルジット; モルト,アンドレア; ディトリッヒ,クラウス; ブロイアー,ミヒャエル; ハルトマン,ホルガー; ケルバー,カルステン; ネスビー,ミヒャエル; シュワブ,マルクス; アイム フリス ニールセン,クルト; フォーリー,クリストフ; ハッシュ,アネル |
シクロクラビン、フェスツクラビン、アグロクラビン、カノクラビン、およびカノクラビンアルデヒドなどのクラビン類アルカロイドを、組換え技術により製造するための微生物およびプロセス、ならびに、クラビン類アルカロイドを製造するための方法に適用することができるポリペプチド、ポリヌクレオチド、およびそうしたポリヌクレオチドを含有するベクターを提供する。【選択図】なし |
29 |
Production of Tetrahydrocannabinolic Acid in Yeast |
US16122702 |
2018-09-05 |
US20180371507A1 |
2018-12-27 |
Jason L. Poulos; Anthony N. Farnia |
Exemplary embodiments provided herein include genetically engineering microorganisms, such as yeast or bacteria, to produce cannabinoids by inserting genes that produce the appropriate enzymes for the metabolic production of a desired compound. |
30 |
Production of cannabidiolic acid in yeast |
US15815651 |
2017-11-16 |
US10093949B2 |
2018-10-09 |
Jason L. Poulos; Anthony N. Farnia |
Exemplary embodiments provided herein include genetically engineering microorganisms, such as yeast or bacteria, to produce cannabinoids by inserting genes that produce the appropriate enzymes for the metabolic production of a desired compound. |
31 |
Genes and processes for the production of clavine-type alkaloids |
US14421872 |
2013-08-13 |
US09828617B2 |
2017-11-28 |
Michael Naesby; Christophe Folly; Curt Aimé Friis Nielsen; Anaelle Hatsch; Markus Schwab; Oskar Zelder; Stefan Haefner; Hartwig Schroeder; Birgit Hoff; Andrea Molt; Klaus Ditrich; Michael Breuer; Holger Hartmann; Karsten Koerber |
Microorganisms and processes for the recombinant manufacture of clavine-type alkaloids such as cycloclavine, festuclavine, agroclavine, chanoclavine and chanoclavine aldehyde, as well as polypeptides, polynucleotides and vectors comprising such polynucleotides which can be applied in a method for the manufacture of clavine-type alkaloids are provided. |
32 |
METHODS OF PRODUCTION OF PRODUCTS OF METABOLIC PATHWAYS |
US15611803 |
2017-06-02 |
US20170268030A1 |
2017-09-21 |
Ron MILO; Lior ZELCBUCH; Niv ANTONOVSKY |
A plurality of isolated polynucleotide sequences encoding enzymes of the astaxanthin pathway is disclosed. The polynucleotides include: (i) a polynucleotide which encodes Phytoene dehydrogenase (crtI) and a first transcriptional regulatory sequence; (ii) a polynucleotide which encodes Beta-lycopene cyclase (lcy-B) and a second transcriptional regulatory sequence; (iii) a polynucleotide which encodes Beta-carotene ketolase (crtW) and a third transcriptional regulatory sequence; and wherein the first, second and third regulatory sequence are selected such that the expression of the Icy-B and the crtW is greater than a level of expression of the crtI. Methods of generating astaxanthin using the plurality of polynucleotide are also disclosed as well as bacterial cells comprising high levels of astaxanthin. |
33 |
Aromatic prenyltransferase from cannabis |
US14510232 |
2014-10-09 |
US09765308B2 |
2017-09-19 |
Jonathan E. Page; Zakia Boubakir |
Nucleic acid molecules from cannabis has been isolated and characterized and encode polypeptides having aromatic prenyltransferase activity. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds. |
34 |
Vectors and strains for producing myrcene and method of producing myrcene using the same |
US14950425 |
2015-11-24 |
US09719095B2 |
2017-08-01 |
Han Min Woo; Eun Mi Kim; Youngsoon Um; Gyeongtaek Gong; Sun Mi Lee; Yunje Kim |
Disclosed herein are an expression vector capable of expressing myrcene, an Escherichia coli strain transformed with the vector and having improved capability of producing myrcene and a method for producing myrcene and a method for recycling glycerol using the same. In an aspect, the transformed Escherichia coli strain of the present disclosure can produce myrcene with high purity on a large scale using glycerol or glucose as a carbon source. Also, the Escherichia coli strain of the present disclosure is economical and environment-friendly because it can produce high value-added myrcene using waste glycerol as a carbon source. In addition, the strongly volatile myrcene can be produced and isolated at the same time. |
35 |
UTILIZATION OF PHOSPHOKETOLASE IN THE PRODUCTION OF MEVALONATE, ISOPRENOID PRECURSORS, AND ISOPRENE |
US15279184 |
2016-09-28 |
US20170198311A1 |
2017-07-13 |
Zachary Q. BECK; Caroline M. PERES; Dmitrii V. VAVILINE; Andrew C. ELIOT |
The invention provides for methods for the production of mevalonate, isoprene, isoprenoid precursor molecules, and/or isoprenoids in cells via the heterologous expression of phosphoketolase enzymes. |
36 |
Methods for Recombinant Production of Saffron Compounds |
US15123198 |
2015-03-06 |
US20170067063A1 |
2017-03-09 |
A.S. Sathish Kumar |
Recombinant microorganisms and methods for producing saffron compounds including crocetin, crocetin dialdehyde, crocin or picrocrocin are disclosed herein. |
37 |
VECTORS AND STRAINS FOR PRODUCING MYRCENE AND METHOD OF PRODUCING MYRCENE USING THE SAME |
US14950425 |
2015-11-24 |
US20170009240A1 |
2017-01-12 |
Han Min WOO; Eun Mi KIM; Youngsoon UM; Gyeongtaek GONG; Sun Mi LEE; Yunje KIM |
Disclosed herein are an expression vector capable of expressing myrcene, an Escherichia coli strain transformed with the vector and having improved capability of producing myrcene and a method for producing myrcene and a method for recycling glycerol using the same. In an aspect, the transformed Escherichia coli strain of the present disclosure can produce myrcene with high purity on a large scale using glycerol or glucose as a carbon source. Also, the Escherichia coli strain of the present disclosure is economical and environment-friendly because it can produce high value-added myrcene using waste glycerol as a carbon source. In addition, the strongly volatile myrcene can be produced and isolated at the same time. |
38 |
Utilization of phosphoketolase in the production of mevalonate, isoprenoid precursors, and isoprene |
US14625487 |
2015-02-18 |
US09493791B2 |
2016-11-15 |
Zachary Q. Beck; Andrew C. Eliot; Caroline M. Peres; Dmitrii V. Vaviline |
The invention provides for methods for the production of mevalonate, isoprene, isoprenoid precursor molecules, and/or isoprenoids in cells via the heterologous expression of phosphoketolase enzymes. |
39 |
VECTOR COMPRISING SPECIFIC PROMOTER AND GENE ENCODING SPECIFIC PROTEIN, TRANSGENIC PLANT INTO WHICH THE VECTOR HAS BEEN INTRODUCED, AND METHOD FOR IMPROVING POLYISOPRENOID PRODUCTION BY INTRODUCING THE VECTOR INTO PLANT |
US15018504 |
2016-02-08 |
US20160244774A1 |
2016-08-25 |
Yukino INOUE; Akari OKADA; Haruhiko YAMAGUCHI; Satoshi KURODA |
Provided is a vector capable of improving polyisoprenoid production through the introduction of the vector into a plant using gene recombination techniques. A vector comprising: a promoter of a gene encoding Hevein 2.1; and a gene encoding a protein involved in polyisoprenoid biosynthesis, the gene being functionally linked to the promoter. |
40 |
CYTOKININ SYNTHASE ENZYMES, CONSTRUCTS, AND RELATED METHODS |
US14718585 |
2015-05-21 |
US20160076010A1 |
2016-03-17 |
William T. Beeson, IV; Patrick John Westfall |
The present disclosure relates to a new class of cytokinin biosynthetic enzymes, cytokinin synthases, which have two domains: an isopentenyl transfer (IPT)-like domain and a cytokinin nucleotide phosphoribohydrolase (PRH)-like domain. The invention provides compositions and methods for the recombinant production of cytokinin synthase, host cells and transformants that include the cytokinin synthases, as well as compositions and formulations that include the disclosed cytokinin synthase. |